Skip to main content
. 2022 Aug 9;13:4677. doi: 10.1038/s41467-022-32149-8

Fig. 5. Cellular immune responses induced by IBV mRNA-LNP vaccines.

Fig. 5

Mice were vaccinated I.D. with a single dose of 5 μg of NP, NA, HA or control luciferase mRNA-LNPs. Splenocytes collected from immunized animals 10 days after immunization were stimulated with NP or NA or HA overlapping peptide pools, and cytokine production by CD4+ and CD8+ T cells was assessed by flow cytometry (a). Percentages of B/Col NP- (p-values left to right 0.0023, <0.0001, 0.028, <0.0001, 0.0004, 0.0478) (b), B/Col NA- (p-values left to right <0.0001, <0.0001, 0.0014, <0.0001, 0.0001, 0.2702) (c), B/Col HA- (p-values left to right 0.1794, 0.0002, 0.0047, 0.0037, 0.0023, 0.1322) (d) and B/Phu HA- (p-values left to right 0.026, <0.0001, 0.0031, 0.0006, 0.0003, 0.5177) (e) specific CD4+ and CD8+ T cells producing IFN-γ, IL-2 and TNF-α are shown. Each symbol represents one animal and error is shown as SEM (n = 8 mice per group for B/Col NP and n = 7 for B/Col NA, B/Col HA, B/Phu HA and luciferase). Statistical analysis: two-tailed unpaired t-test, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗p < 0.0001. Source data are provided as a source data file.